Financial Analyst Intern
Danaher Corporation
Summary
This position is part of Finance Team located in Chaska, MN and will be on-site. At Beckman Coulter, our vision is to relentlessly reimagine healthcare, one diagnosis at a time.
Job description
You will be part of the US Manufacturing Finance Team and report to Finance Manager responsible for Chaska Operations Finance and Accounting. If you want to work in a fast-paced, collaborative, world-class manufacturing organization - read on.
In this role, you will have the following opportunities, but are not limited to:
- Partner with Chaska Manufacturing Team and collaborate with other cross functional teams within Operations Group
- Perform operational accounting which mainly involves Standard Costing, Inventory, Excess and Obsolete, Cycle Count, Scrap.
- Complete month-end close processes which include journal entries and account reconciliation
- Working with buyers and Accounts Payable team in resolving aging/unmatched Purchase Orders and Invoices
- Adhoc – Reporting Production Volume, researching Bill of Materials, Materials Usage and Purchase Price Variance
The essential requirements of the job include:
- Bachelor’s degree program in Accounting or Finance
- Knowledgeable in Microsoft Applications
It would be a plus if you also have:
- Excellent communication and relationship building skills
- Quick learner, independent, and analytical
Requirements
- Currently enrolled in a Bachelor’s degree program in Accounting or Finance
- Knowledgeable in Microsoft Applications
- Excellent communication and relationship building skills
- Quick learner, independent, and analytical
Company overview
Danaher Corporation is a leading global science and technology innovator headquartered in Washington, D.C., specializing in biotechnology, life sciences, and diagnostics. Founded in 1984 by brothers Steven and Mitchell Rales, the company has evolved from its origins as a manufacturing conglomerate into a premier healthcare technology organization with approximately 63,000 employees worldwide. Danaher operates through three core divisions: biotechnology (28% of revenues), which develops products for therapeutic development; life sciences (31% of revenues), focused on disease identification, new therapies, and drug testing/manufacturing; and diagnostics (41% of revenues), providing instruments, consumables, and software for disease diagnosis. The company's portfolio includes renowned brands such as Beckman Coulter, Cytiva, Pall Corporation, Cepheid, Leica Microsystems, and Abcam, serving pharmaceutical companies, biotechnology firms, healthcare providers, and research institutions globally. Danaher is distinguished by its Danaher Business System (DBS), a continuous improvement methodology that drives innovation and operational excellence. With 2024 revenues of $23.9 billion, the company ranks 180th on the Fortune 500 and plays a critical role in advancing scientific research, improving diagnostic capabilities, and accelerating the development of life-saving therapies.